Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).

about

Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).

Item

http://www.wikidata.org/entity/Q47396324

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Dosing strategies to optimize ...... options (Part 2: PO options).

@en

Dosing strategies to optimize currently available anti-MRSA treatment options

@nl

type

Item

label

Dosing strategies to optimize ...... options (Part 2: PO options).

@en

Dosing strategies to optimize currently available anti-MRSA treatment options

@nl

prefLabel

Dosing strategies to optimize ...... options (Part 2: PO options).

@en

Dosing strategies to optimize currently available anti-MRSA treatment options

@nl

P1476

Dosing strategies to optimize ...... options (Part 2: PO options).

@en

P2093

Amrita Das

http://www.w3.org/2001/XMLSchema#string

Kenna D Payne

http://www.w3.org/2001/XMLSchema#string

Michelle Ndiulor

http://www.w3.org/2001/XMLSchema#string

Ronald G Hall

http://www.w3.org/2001/XMLSchema#string

P2860

The changing epidemiology of Staphylococcus aureus?

Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus

Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection

Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines

Fractal Geometry-Based Decrease in Trimethoprim-Sulfamethoxazole Concentrations in Overweight and Obese People.

Efficacy and safety of linezolid in liver transplant patients.

Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.

Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.

Clinical population pharmacokinetics and toxicodynamics of linezolid.

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17512433.2018.1411800

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29186999

http://www.w3.org/2001/XMLSchema#string